REG - Esken Limited - Notice of Results

EskenAnnouncement

27/10/2021 07:05

RNS Number : 3548Q
  
Esken Limited
  
27 October 2021
  
 

27 October 2021
Esken Limited
("Esken" or the "Group")
 
 Notice of Results
Interim results presentation
 
Esken, the aviation and energy infrastructure group, will announce its interim results for the six months ended 31 August 2021 on 3 November 2021.
 
The Company will hold an investor presentation at 09:30 a.m. UK time on Wednesday 3 November 2021 hosted by David Shearer, Executive Chairman and Lewis Girdwood, Chief Financial Officer.
 
The presentation will be hosted through the digital platform Investor Meet Company. The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation.
 
Investors can sign up to Investor Meet Company for free and add to meet ESKEN LIMITED via: https://www.investormeetcompany.com/esken-limited/register-investor. 
 
Investors who already follow ESKEN LIMITED on the Investor Meet Company platform will automatically be invited.
 
Enquiries:
Esken Limited    C/o Tulchan Communications
Charlie Geller, Group Communications Director



Tulchan Communications
Olivia Peters / David Allchurch / Giles Kernick 
020 7353 4200
esken@tulchangroup.com 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
NORMFBBTMTBTTTB